UK markets close in 35 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.77-1.22 (-11.06%)
As of 10:55AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate-0.99-0.97-3.93-3.39
Low estimate-1.17-1.15-4.64-4.41
High estimate-0.86-0.82-3.2-2.85
Year ago EPS-1.92-1.56-6.09-3.93
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4454
Avg. Estimate190k190k600k7.02M
Low estimate100k100kN/AN/A
High estimate250k250k1M17.08M
Year ago sales114k226k832k600k
Sales growth (year/est)66.70%-15.90%-27.90%1,070.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.74-1.74-1.52-1.27
Actual EPS-1.92-1.56-1.56-1.12
Difference-0.180.18-0.040.15
Surprise %-10.30%10.30%-2.60%11.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.99-0.97-3.93-3.39
7 days ago-0.99-0.97-3.93-3.39
30 days ago-0.99-0.97-3.93-3.39
60 days ago-0.83-0.8-3.57-2.64
90 days ago-0.07-0.07-0.3-0.25
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesINOIndustrySector(s)S&P 500
Current qtr.48.40%N/AN/AN/A
Next qtr.37.80%N/AN/AN/A
Current year35.50%N/AN/AN/A
Next year13.70%N/AN/AN/A
Next 5 years (per annum)41.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A